Financhill
Back

Sarepta Therapeutics Vs. Regenxbio Industry Stock Comparison

Sell
31

SRPT
Sarepta Therapeutics

Last Price:
110.51
Seasonality Move:
16.38%
Sell
21

RGNX
Regenxbio

Last Price:
9.21
Seasonality Move:
-5.66%
Sell
31
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $110.86. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.63. The Score for RGNX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $110.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.05 Sell
Relative Strength Index (14 RSI): 37.69 Sell
Chaikin Money Flow: 693876 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.82 - 130.18) Sell
Bollinger Bands (100): (120.21 - 144.19) Sell

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 46.24 Sell
Chaikin Money Flow: 454637 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.02 - 10.78) Sell
Bollinger Bands (100): (9.89 - 12.81) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.05 Buy
20-day SMA: 119.95 Sell
50-day SMA: 122.58 Sell
200-day SMA: 130.17 Sell
8-day EMA: 110.83 Buy
20-day EMA: 116.6 Sell
50-day EMA: 122.63 Sell
200-day EMA: 126.32 Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.36 Sell
20-day SMA: 9.79 Sell
50-day SMA: 10.41 Sell
200-day SMA: 14.29 Sell
8-day EMA: 10.03 Sell
20-day EMA: 10.04 Sell
50-day EMA: 10.44 Sell
200-day EMA: 13.26 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):